P22-Based Nanovaccines against Enterohemorrhagic Escherichia coli is a research paper published in Microbiology Spectrum (2023). On theSindex it has a DataRank of 0.398. It has been cited 7 times, with 4 citing works in its 1-hop citation network.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.312
From this paper's citation signal
Citation Network Contribution
0.0857
From 2 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 4 citers.
Division of Intramural Research, National Institute of Allergy and Infectious Diseases
Grant: AI155844
Universidad Nacional Autónoma de México
Grant: DGAPA-PAPSA
UTMB | Sealy Institute for Vaccine Sciences, University of Texas Medical Branch
Grant: N/A
U.S. Department of Agriculture
Grant: NBAF
NIAID NIH HHS
Grant: R01 AI126601
National Institutes of Health
Grant: 5R21AI155844-02
Developing effective nanovaccines against pathogenic Escherichia coli
FWCI
1.78
Citation Percentile
0.8%
Influential Citations
1
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals